AD, The most common inflammatory skin disorder worldwide, is a highly heterogeneous condition with current treatments that do ...

Long-term lebrikizumab was effective for atopic dermatitis treatment in patients who did not have adequate response to short-term treatment.

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Data from a retrospective multicenter study, along with a review of previous trials, supported the real-world utility of ...

Having asthma, Hashimoto’s thyroiditis or atopic dermatitis in addition to alopecia areata raised the odds for early-onset, severe and prolonged alopecia areata, according to a research letter ...

As temperatures drop, many people experience dry, red, and itchy skin, a condition that often worsens in winter.

Atopic dermatitis, the most common type ... Other factors, such as elevated levels of inflammatory substances in the vulva, may also be contributing factors. Is Dermatitis Chronic? Dermatitis is ...

The celebrity dermatologist talks about finding her moment of clarity in finding relief for her eczema symptoms and how she ...

Sanofi aims to boost competition in the atopic dermatitis market, following Dupixent's success, with new treatments like SAR444656 and amlitelimab in development.

Atopic dermatitis, affecting 10% to 20% of children globally, is marked by chronic inflammation and varied complications, including infection risks.

In the last few months, Pfizer has won approvals in the EU and US for JAK inhibitor Cibinqo (abrocitinib) as a treatment for moderate-to-severe atopic dermatitis in adults who cannot get relief ...

Eczema is not contagious, and is a chronic disease that causes symptoms of dry, itchy skin that can appear like a red rash, with some patients reporting a burning sensation, tingling or stinging.